16 results
Vasopressors Table 
Rough properties by Target Receptor, Heart Rate/Inotropy, Systemic Vascular Resistance, Cardiac Output, Blood Pressure,
Vasopressors Table ... Dobutamine 2-20 mcg ... Vasopressors #Properties #Table ... #Pharmacology # ... Effect #Management
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
chew, or crush tablet ... suspension 4–6 mL ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
Drugs Used for the Treatment of COVID-19 Infection

** Editor Note (from ophthalmology MD input) - Hydroxychloroquine/chloroquine
More precisely "macular ... Even with macular ... Treatment #COVID19 #Pharmacology ... #Table #Management
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
100 cells/mm3 g/mL ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
if MIC<0.12 ug/ml ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
Fentanyl Conversion Table
Fentanyl patch 25 mcg/hr = Morphine PO 50 mg/day
Fentanyl patch 50 mcg/hr = Morphine
Fentanyl Conversion Table ... Fentanyl patch 25 mcg ... Fentanyl #Conversion #Table ... #pharmacology # ... pain #management
Diuretics and Agents Regulating Renal Excretion

Carbonic Anhydrase Inhibitors (Acetazolamide, Dichlorphenamide)
 • Glaucoma
 • Epilepsy
 • Altitude
irrigation • Management ... Inhibitors of Na+K+2Cl ... Diuresis #Nephrology #Pharmacology ... #Medications #Table
IDSA Recommendations for Preventing and Treating Histoplasma Capsulatum Infections in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
with ARV (see Table ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
Castleman’s Disease (MCD ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Treponema pallidum Infections (Syphilis) to Prevent Disease in HIV-AIDS
Early Stage (Primary, Secondary,
consultation to guide management ... Neurosyphilis, Otic, or Ocular ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology